On the morning of August 5, Chairman Xie Jianzhong led a delegation, joined by Xie Xuanhui, Founding Partner of TVM Capital's China office, an internationally renowned investment firm, to visit the Zhengzhou Airport Economy Zone and study its planning for the biomedical and big health industries. That afternoon, Tian Haitao, Deputy Secretary-General of the Provincial Government and Director of the Zhengzhou Airport Economy Zone Administrative Committee, led an official delegation to the company to inspect its biomedical industry, accompanied by Xuchang leaders including Municipal Party Secretary Yang Xiaojing and Deputy Municipal Party Secretary and Mayor Zhang Qingyi. Chairman Xie Jianzhong hosted the visit and briefed the delegation on the company's development.

Focused on becoming a new core growth engine for the province's high-quality economic development, the Zhengzhou Airport Economy Zone has delivered remarkable results. Bordering Xuchang and sharing complementary industries, the Zone is advancing the Zhongyuan Medical Science City, developed in an integrated manner with the Provincial Academy of Medical Sciences and the Provincial Academy of Traditional Chinese Medicine Sciences. Supported by landmark projects including the Big Health Industry Innovation Base and the Life Sciences Valley, it is committed to building a world-class biomedical and big health industrial cluster, having already attracted over 200 registered companies.

  The delegation toured Newland's exhibition hall and R&D center. Chairman Xie Jianzhong guided the visit, presenting a full picture of the company's development with special emphasis on its technology R&D and innovation capabilities. Newland's Party-led, pragmatic, united and innovation-driven growth left a deep impression on the visiting leaders, and Director Tian spoke highly of the company's achievements.

  Chairman Xie Jianzhong expressed heartfelt thanks to the leaders of the Airport Economy Zone and Xuchang for their support. He noted that Newland's 2025–2030 strategy is closely aligned with the development goals of the pharmaceutical industry in both regions. With the strong support of the leaders, the company will step up exchanges with pharmaceutical enterprises in the Zone, learn from advanced experience and models, stay innovation-led and firmly execute its strategy, and explore deeper cooperation in the biomedical and big health sectors — jointly contributing to the high-quality development of the pharmaceutical industry across the two regions and the province.